Abstract: Matching tissue engineering scaffold modulus to that of native tissue is highly desirable. Effective scaffold modulus can be altered through changes in base material modulus and/or scaffold pore architecture. Because the latter may be restricted by tissue in-growth requirements, it is advantageous to be able to alter the base material modulus of a chosen scaffold material. Here, we show that the bulk modulus of poly(glycerol sebacate) (PGS) can be changed by varying molar ratios during prepolymer synthesis and by varying curing time. We go on to show that PGS can be used to create 3D designed scaffolds via solid freeform fabrication methods with modulus values that fall within the ranges of native articular cartilage equilibrium modulus. Furthermore, using base material modulus inputs, homogenization finite element analysis can effectively predict the tangent modulus of PGS scaffold designs, which provides a significant advantage for designing new cartilage regeneration scaffolds. Lastly, we demonstrate that this relatively new biomedical material supports cartilaginous matrix production by chondrocytes in vitro.
INTRODUCTION
Polymer scaffolds will play a key role in treating cartilage defects, deterioration, and damage caused by aging, disease, and trauma. There are a number of synthetic materials and a wide range of fabrication methods being applied to make such scaffolds, with the general acceptance that these constructs should be biocompatible, biodegradable, and mechanically stable. Here, we focus on the requirement that a scaffold should have mechanical properties, particularly tangent modulus values, in the range of native cartilage equilibrium modulus values. There are two components that determine the final effective scaffold modulus: (1) the base material modulus and (2) the scaffold pore architecture. As pore geometry may be restricted by tissue in-growth requirements, it would be advantageous to be able to alter effective scaffold modulus simply by altering the base material modulus. We show how the processing conditions of poly(glycerol sebacate) (PGS) can be varied to tailor the mechanical properties of three-dimensionally designed, solid-freeform fabricated (SFF) scaffolds for cartilage tissue engineering.
Poly(glycerol sebacate) has been recently developed for tissue engineering. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Synthesis and characterization of the polymer, created through a polycondensation reaction of glycerol and sebacic acid, was first reported for use in biotechnology and bioengineering in 2002 1 to provide good mechanical properties and rubber-like elasticity, established degradation and crosslinking mechanisms optimal for soft tissue engineering applications. Along with being tougher, less expensive and more flexible than existing biodegradable elastomers, glycerol is a humectant used in foods and beverages, and polymers containing sebacic acid (e.g., Polifeprosan) have been approved by the US Food and Drug Administration for drug delivery applications. To date, PGS has been studied for applications in nerve guidance, 2 soft tissue regeneration, 3, 4 vascular and myocardial tissue regeneration, [5] [6] [7] [8] [9] blood vessel reconstruction, 10 ,11 drug delivery, 12 and replacement of photo-receptor cells. 13 PGS is a biodegradable polymer with biocompatibility and mechanical properties that make it well suited for applications such as those mentioned and, as we show here, for use in cartilage tissue engineering.
PGS is processed by creating a prepolymer, and then curing the prepolymer at high temperatures to obtain a thermoset elastomeric polymer. Most studies have fabricated the polymer through conventional methods, creating films or porogen-leached sponges. The most advanced structures reported are tubular sheets and films developed as scaffolds for blood vessels, renal tubules or various ducts. 10, 11 In this work, we demonstrate the ability to process PGS using SFF techniques to create scaffolds with designed pore shapes, pore sizes, porosities, and architectures. In the past, this fabrication has been widely used in our lab [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] to make designed scaffolds from poly(L-lactic acid), poly(lactic-co-glycolic acid), poly(e-caprolactone), hydroxyapatite, poly(propylene-fumarate), and poly(propylene-fumarate)/tricalcium phosphate blends for applications in bone regeneration, spinal cord reconstruction, and cartilage tissue engineering. Because most of these materials, when fabricated into three-dimensional (3D) designed scaffolds, exhibit mechanical properties that are outside the ranges of cartilage, we have more recently applied this technology to more elastomeric materials, such as poly(glycerol sebacate) (PGS) and poly(1,8-octanedial-co-citrate) (POC) for cartilage tissue engineering applications. 24 We believe that the mechanical properties of these materials make them ideal for use in fabricating scaffolds for load bearing articular sites. Fabrication of PGS by this means is not yet reported.
One of the main advantages of using PGS for tissue engineering is that its mechanical properties can be tailored to match specific tissue properties through altering processing parameters during the prepolymer and/or curing steps. In 2008, Chen et al. 7 demonstrated the ability to alter the mechanical properties of PGS for myocardial tissue applications through changing curing temperature, recording Young's modulus values of 0.056 MPa (1108C), 0.22 MPa (1208C), and 1.2 MPa (1308C). In this work, we evaluate how changing the molar ratios of glycerol:sebacic acid during prepolymer synthesis and how changing the curing time causes variations in nonlinear elastic mechanical properties.
The purpose of this work is to assess PGS as a scaffolding material for cartilage tissue engineering by determining how synthesis conditions affect both bulk PGS properties and PGS scaffolds with designed architecture. As the use of PGS for cartilage regeneration has not yet been reported, we further demonstrate that PGS scaffolds support robust cartilage formation when seeded with porcine chondrocytes in vitro.
MATERIALS AND METHODS

Fabrication of PGS solid cylinders and 3D-designed scaffolds
Prepolymer synthesis PGS prepolymer (pPGS) was synthesized following methods described by Gao et al. 4 Three batches of pPGS were synthesized with various molar ratios of sebacic acid:glycerol (3:4, 1:1, and 4:3). Sebacic acid and glycerol were reacted under N 2 at 1208C. After 24 h, the N 2 was removed and a vacuum of 50 mTorr was pulled for an additional 48 h, with a condenser attached.
Polymer curing
Prepolymer was cured through a modified protocol 4 that enabled fabrication of designed architecture scaffolds from wax molds. To create solid cylinders for mechanical testing, the prepolymer was poured into a Teflon mold and cured at 1508C for various time points (24 h w/out vacuum plus 24, 48, or 72 h with a 100 mTorr vacuum). A 3D scaffold (3 mm height, 6.35 mm diameter, 1 mm spherical pores, and 54% porosity) was designed using custom Interactive Data Language TM programs (IDL; Research Systems, Boulder, CO). 15, 16 To fabricate designed scaffolds, wax molds of the final scaffold design were made on a Solidscape printer (Solidscape, Merrimack, NH). Wax molds were pressed into hydroxyapatite (HA) following a protocol previously established in the lab, 24 resulting in an inverse HA mold. The inverse HA mold was pressed into pPGS that had been poured into a Teflon mold. 25 The Teflon/pPGS/HA mold unit was placed within a vacuum oven to cure at 1508C. For the first 24 h, no vacuum was pulled, to allow the prepolymer to begin to cure, preventing air bubbles from forming in the polymer when a vacuum is pulled. After 24 h, a strong vacuum (100 mTorr) was pulled, and the temperature was maintained at 1508C for 24, 48, or 72 h longer. The HAþPGS construct was removed from the cup, and the HA was dissolved out using a rapid decalcifying agent (RDO, Apex Engineering, Aurora, IL) to achieve the final PGS scaffold. The schematic of this process is shown in Figure 1 . PGS scaffolds and cylinders were autoclaved and rinsed overnight in DMEM before mechanical testing or chondrocyte seeding. Cylinder and scaffold diameters were measured before and after rinsing in DMEM. Note, curing times reported in the results section refer to the hours cured after a vacuum was pulled (24, 48 , and 72 h).
Fabrication of 3D-designed PCL control scaffolds
For in vitro testing experiments, control 3D polycaprolactone (PCL) scaffolds were made using the design previously described for PGS scaffolds (3 mm height, 6.35 mm diameter, 1 mm spherical pores, and 54% porosity). PCL scaffolds were made by pressing these wax molds directly into melted 37 kDa polycaprolactone (CAPA 6400, Solvay Caprolactones, Warrington, Cheshire, UK). Briefly, PCL pellets were placed into a Teflon mold and melted (1158C, 1 Torr, 120 min). After melting and air bubble removal, the Teflon mold was pulled from the oven and allowed to cool for 270 s at room temperature, reaching 808C (just below the melting temperature of the wax molds). At this time, inverse wax molds were pressed into the melted PCL, and the entire construct was cooled overnight. Wax was dissolved from the PCL using 100% EtOH.
Microcomputed tomography image analysis
To assess defects and create images for finite element analysis (FEA), solid cylinders and scaffolds were scanned using a MS-130 high resolution (CT scanner (GE Medical Systems, Toronto, CAN) at a 16-lm voxel resolution. Scans were performed in air at 75 kV and 75 mA. GEMS Microview software (GE Medical Systems, Toronto, CAN) was used to view reconstructed images.
Mechanical testing
Solid PGS cylinders and PGS 3D-designed scaffolds were tested in compression using an MTS Alliance RT30 electromechanical test frame (MTS Systems Corp., MN).
Stress-relaxation in confined compression
Stress-relaxation tests were performed in confined compression following a protocol established by Guilak et al. 26 and used extensively in the field by others. 27, 28 Briefly, presoaked samples were loaded into a confining cylindrical chamber filled with a phosphate-buffered saline solution controlled at 378C. A porous indenter was lowered until a reading of 0.22N was output on the computer, signifying that the indenter was in contact with the cylinder or scaffold. This load was held for 600 s and assumed to be the 0% strain position. Under displacement control, stress-relaxation testing was performed with a single ramp of 20% strain applied at 0.25 lm/s or 5 lm/min. The crosshead was then held at constant displacement for 30 min to record relaxation.
Unconfined compression
Unconfined compression tests were performed on solid cylinders (n 5 5-10 for each group, with variation in sample size due to exclusion of cylinders with defects) under displacement control. Samples were compressed to failure in the z-direction between two fixed steel platens at a rate of 2 mm/min after a preload of 0.05 lb was applied. A single set of 3D-designed scaffolds were fabricated (n 5 7) (1:1 molar ratio, 48 h cure time) and tested in unconfined compression to validate FEA predictions.
Finite element analysis
Complete anisotropic effective stiffness constants were calculated using the voxel-based homogenization software VOXELCON (Quint Corp, Tokyo, Japan), as described previously. 23 STL design files were converted to .vox files, and PGS modulus values from mechanical testing of solid cylinders (3 molar ratios 3 3 curing times) were input into VOXELCON, with a Poisson's ratio of 0.3 and run on scaffold designs.
In vitro study
Chondrocyte harvest
Cartilage was harvested from fresh metacarpophalangeal joints of domestic pigs obtained from a local abattoir Figure 1 . Fabrication of 3D designed PGS scaffolds involves first creating wax molds, which are cast into hydroxyapatite to create an inverse mold, which is then cast into PGS prepolymer and cured, resulting in a PGS scaffold.
(Northwest Market, Northwest, MI). Cartilage pieces were digested in a digest solution [DMEM high glucose, serum free, 1 mg/mL collagenase II (Sigma No. C1764), 2% Pen/ strep, 2% kanamycin (Roche, 12728700), and 0.2% Fungizone (Invitrogen, 15290-018)] on a stir plate for 6 h at 378C, 5% CO 2 . The solution was then filtered through sterile nylon. Cells were spun at 2000 rpm for 8 min, and plated overnight on tissue culture polystyrene in DMEM þ 10%FBS þ 1% P/S þ 50 lg/mL 2-phospho-L-ascorbic acid (BioChemika, 49752). The following day, cells were trypsinized and immediately suspended in collagen gel for scaffold seeding.
Cell seeding and in vitro culture PGS scaffolds (1:1 molar ratio, 48 h cure time) were sterilized in an autoclave and presoaked in DMEM for 24 h before cell seeding. Chondrocytes were suspended in a composite 5% Hyaluronic Acid (HyA) (stock concentration: 2.7 mg/mL in 0.8M NaCl, MW: 3 3 10 6 Da: Hyalogic LLC, Edwardsville, KS) info)/collagen I gel (stock concentration: 5.9 mg/mL, BD Biosciences, No. 354236) at $30 3 10 6 cells/mL. 4% v/v 0.5M sodium hydroxide with 220 mg/mL sodium bicarbonate was used to increase the pH of the collagen/HyA/cell suspension just before seeding into the scaffolds to create gelling at 378C. Cells were evenly seeded into scaffolds using a custom designed Teflon mold. After gelling ($30 min), scaffolds were removed from the mold. Scaffold þ Cells þ Gel constructs were cultured in an incubator (378C, 5% CO 2 ) in 24-well plates on an orbital shaker for 2 weeks. Media (DMEM, 10%FBS, 1% P/S, 0.1 mM nonessential amino acids, 50 lg/mL 2-phospho-L-ascorbic acid, 0.4 mM proline, 5 lg/mL insulin) was changed every other day. PCL control scaffolds were seeded and cultured in the same manner.
Histological staining
After 2 weeks, PGS scaffolds (n 5 2) were removed, fixed in 10% buffered formalin phosphate (Fisher, SF100-20) overnight, dehydrated in EtOH washes, and paraffin embedded. Histological sectioning was performed $1500 lm from the scaffold surface (at approximately the mid point of the scaffold) and sections were stained with Alcian Blue to illustrate GAG production.
Sulfate-glycosaminoglycan (sGAG) quantification At 2 weeks, PGS scaffolds (n 5 3) and control PCL scaffolds (n 5 3) were removed from culture, finely chopped, and placed immediately into 1 mL of papain solution (papain, 13 PBS, cysteine HCL, EDTA, pH 5 6.0; mixed for 3 h at 378C then filtered). Scaffolds were digested in papain for 24 h and then immediately frozen at 2208C. A DMMB assay was run on digested scaffolds. Briefly, 20 lL of sample was mixed with 200 lL of dimethylmethylene blue reagent and absorbance was immediately read on a plate reader (MultiSkan Spectrum, Thermo, Waltham, MA) at 525 nm. 29 Readings were compared with a standard curve established from chondroitin 6-sulfate from shark (Sigma, C4384).
DNA quantification
Papain digested PGS scaffolds (n 5 3) and control PCL scaffolds (n 5 3) were also used to determine DNA content through a Hoechst 33258 Assay (Sigma, No. 861405). Briefly, 100 lL digested sample was added to 100 lL Hoechst and read with excitation: 355 nm, emission: 460 nm (Fluoroskan Ascent FL, Thermo, Waltham, MA) in a 96-well plate. Readings were compared with standards made from calf thymus DNA (Sigma, No. D0805).
Quantitative-PCR qtPCR was used to determine the expression of cartilage specific genes (collagen II and aggrecan), a chondrocyte dedifferentiation marker (collagen I), and a house-keeping gene (GAPDH). Scaffolds were removed from culture, rinsed twice with PBS, cut into small pieces ($1 mm 3 ), and placed immediately into RNAlater (Qiagen, D-40724). Scaffolds were incubated in RNAlater at 48C for 24 h then transferred to 2208C for storage. For RNA extraction, scaffold þ tissue were homogenized in Buffer RLT for $60 s. Lysate was then centrifuged, and supernatant was removed. RNA was extracted using an RNeasy Mini Kit (Qiagen No. 74104), and samples were stored at 2808C. After measurement of RNA concentration for each sample, first-stand cDNA was synthesized using random primers (Superscript Kit No. 18064). Samples were prepared for qtPCR using a Taqman universal PCR master mix (Applied Biosystems, 4304437) and custom designed porcine primers. qtPCR was then performed using an ABI PRISM 7700 (Applied Biosystems, Foster City, CA). As a control, before seeding, 5 3 10 6 chondrocytes were incubated in RNAlater and used for qtPCR.
Statistical analysis
Multiple linear regression was performed using SPSS software (SPSS for Windows, Rel 14.0. 2005 Chicago: SPSS).
RESULTS
Fabrication of cylinders and scaffolds
Caliper measurements of PGS cylinder and scaffold diameters showed no significant swelling of constructs after soaking in DMEM for 24 h (average solid cylinder diameter before DMEM soak 5 6.45 mm 6 0.03 mm, after soaking 5 6.46 mm 6 0.03 mm; average scaffold diameter before DMEM soak 5 6.43 mm 6 0.03 mm, after soaking 5 6.44 mm 6 0.02 mm). Micro-CT analysis of solid cylinders confirmed the absence of air bubble defects in these mechanical testing specimens. Successful fabrication of designed scaffolds can be seen in Figure 2 , where l-CT analysis of scaffolds, again, confirms the absence of defects [ Fig. 2(a,b) ]. Volume fraction quantification done on l-CT images reveals that the porosity of fabricated scaffolds (48.1% 6 4.24%) is slightly less than that of the design file (54%), whereas scaffold pore diameters (1.04 mm 6 0.04 mm) are equal to designed pore sizes (1.0 mm). Decreased porosity of actual scaffolds is most likely due to small amounts of PGS penetrating into pores.
Mechanical property variations
Stress-relaxation testing done on solid cylinders (n 5 2 for each molar ratio/cure time) revealed that PGS does not exhibit a viscoelastic response. Stress-relaxation profiles were not dependent on strain rate (0.25 lm/s vs. 5 lm/s), nor did they relax under constant displacement after loading (Fig. 3) , indicating that PGS exhibited predominantly elastic properties and therefore, PGS bulk and scaffolds were tested in unconfined compression and fit to a 1D nonlinear elastic model commonly used for biological soft tissues:
where T is the 1st Piola-Kirchoff stress, e is the large strain, and A and B are model parameters fit to experimental data. The fit was performed using a specially written MATLAB program calling the optimization function fminunc. The tangent modulus at 10% strain was calculated as follows: 
Representative curve fits for solid cylinders and 3D scaffolds can be seen in Figure 4 .
As seen in Figure 5 , the tangent elastic modulus of PGS is significantly altered through variations in prepolymer molar ratios and curing times. Multiple regression provided a powerful (predictive power, adjusted R 2 5 0.70) linear equation for tangent modulus (at 10% strain) dependent on these two variables: y 5 3.607-1.410 * (molar ratio of glycerol: sebacic acid) þ 0.60 * (curing time in hours).
Homogenization finite element analysis
Homogenization FEA was used to calculate the tangent elastic modulus values of scaffold design files and l-CT images of actual scaffolds using values of solid cylinder tangent modulus at 10% strain. Table I displays experimental modulus values of solid cylinders, FEA predictions of modulus values for a 3D scaffold from design files, and modulus values from experimentally tested scaffolds. The voxel model is able to accurately predict the tangent modulus of scaffolds from the design file (prediction 5 0.60 MPa, actual 5 0.57 6 0.24).
In vitro study
Chondrocytes suspended in collagen 1/5% hyaluronic acid composite hydrogel within 3D designed scaffolds maintained a rounded morphology and produced a cartilaginous matrix as seen in digital images and through alcian blue staining in Figure 6 . Sulfated-GAG concentrations were within the same ranges as chondrocytes cultured under identical conditions on poly(e-caprolactone) (PCL) of the same architectural design (29.64 6 11.87 vs. 33.00 6 6.24 lg GAG/lg DNA, respectively). Collagen 2: collagen 1 ratios were higher for chondrocytes cultured on PGS than those cultured under identical conditions on PCL (20.91 6 3.25 vs. 8.69 6 0.17), but were lower than mRNA expression by unseeded chondrocytes (267). Aggrecan expression by cells on PGS was similar to cells seeded on PCL (1.74 6 0.68 vs. 1.67 6 0.07), and both expression levels were higher than expressed by preseeded chondrocytes (0.37). Note: ''preseeded'' refers to an aliquot of cells taken immediately before seeding the batch of cells onto a scaffold.
DISCUSSION AND CONCLUSIONS
We have presented a novel PGS scaffold fabrication method. Actual scaffold pore sizes and porosities showed no major deviations from design files, and there is no significant swelling of solid cylinders or scaffolds when they are soaked in DMEM.
It is highly desirable to be able to match effective scaffold mechanical properties to native tissue properties for scaffolds designed for optimal tissue regeneration. Intuitively, one way in which the mechanical properties of a scaffold can be altered is through changing the structural features, such as pore size, porosity, interconnectivity, and pore shape. 15, 30 However, changing these features also has an effect on cartilage tissue regeneration. [31] [32] [33] [34] [35] [36] Working with a material whose intrinsic elastic properties can be altered enables fabrication of scaffolds with a wide range of architectures (designed for optimal tissue regeneration) from one material, all of which will support in vivo loads. PGS is beneficial in this respect, as its mechanical properties can be varied simply through changing the molar ratios of glycerol to sebacic acid during prepolymer synthesis or varying the duration of curing.
After establishing a collection of bulk mechanical properties for nine processing combinations (3 molar ratios 3 3 curing times), we used FEA to predict the elastic moduli of a 3D designed scaffold fabricated from these various batches of PGS. A single batch of scaffolds, fabricated from an intermediate of the nine processing combinations, verified that modulus values reported through FEA are reasonable estimates. This demonstrates the ability of image-based homogenization FEA to compute the effective tangent modulus of PGS scaffolds without the need for destructive testing.
Although PGS does not exhibit viscoelastic properties, the ability to match the elastic modulus of scaffolds to the equilibrium elastic properties of native cartilage is a step in the right direction, as this component is responsible for providing shape retention and strength. In comparison, a current clinical treatment, autologous chondrocyte implantation, has shown some success without any substantial mechanical support. 37 However, patients must be extremely careful not to overload the delicate periosteal flap which envelopes the repair site. This draws a thin line between the amount of postoperative mechanical loading shown to enhance tissue regeneration, and the amount that will damage the graft. 38 Incorporating a scaffold that matches the equilibrium elastic properties of native articular cartilage will allow for some degree of postoperative loading, a more robust environment to retain cell implantation, and temporary mechanical support that closely mimics the support provided by surrounding healthy tissue. Furthermore, this data can be applied to other soft tissue engineering applications that PGS is being studied for, such as myocardial tissue, 7 where nonlinear elastic properties are highly desirable. The equilibrium elastic properties of experimental cartilage data can be separated out using the following equation:
where H A is the aggregate modulus, E is the equilibrium elastic component of this modulus, and v is the Poisson's ratio. Poisson's ratio was assumed to be 0.3, as experimentally measured by Cohen et al. 39 With literature showing H A values of healthy articular cartilage ranging from 0.089 MPa to 2.22 MPa, 27, 28, [40] [41] [42] [43] [44] [45] [46] [47] [48] the calculated equilibrium elastic component (E) ranges from 0.04 to 0.99 MPa. As displayed in Figure 7 , elastic modulus values predicted for this particular scaffold design from the collection of PGS bulk properties range from 0.03 to 1.13 MPa, completely encompassing the native tissue values that one might wish to match.
Furthermore, an in vitro experiment shows that PGS can indeed be used for cartilage tissue engineering applications where chondrocytes are seeded within a scaffold to produce a cartilaginous matrix. Aggrecan is expressed in higher levels on PGS scaffolds than in preseeded cells, showing favorable trends toward chondrogenesis. Collagen 2: collagen 1 ratio, commonly referred to as a ''differentiation index'' for chondrocytes, 49 where a larger value represents more chondrogenic gene expression and a lower value represents more fibroblastic gene expression, is higher on PGS than on identical studies done using PCL. Differences between expression levels on PGS versus PCL may be related to the hydrophilicity of PGS which may enhance cell adhesion, retain more sGAG, and more closely mimic the native hydrophilic nature of cartilage ECM; however, further studies need to be done to verify this hypothesis.
PGS is a good candidate for cartilage tissue engineering applications. As shown for the first time, it can be fabricated into 3D-designed scaffolds using SFF techniques and is biocompatible with chondrocytes in vitro. Its bulk mechanical properties can be altered during synthesis and curing to match stiffness values of 3D-designed scaffolds to those of native cartilage. Furthermore, scaffold modulus values can be predicted using FEA, eliminating the need for destructive testing on custom scaffolds.
